CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Columbia University
Columbia University
Columbia University
National Cancer Institute (NCI)
University of California, San Francisco
Fred Hutchinson Cancer Center